The article accurately reports that the World Health Organization (WHO) has strongly criticized a planned US-funded hepatitis B vaccine trial in Guinea-Bissau for newborns. The WHO deemed the trial's design, which involves randomizing newborns to receive the vaccine at different times (birth vs. six weeks), as "unethical." While factually sound, the article exhibits some bias by using strong emotive language like "blasted" and focusing solely on the critical perspective without presenting the trial's rationale.
